192 related articles for article (PubMed ID: 8442324)
1. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
Hellmén E; Bergström R; Holmberg L; Spångberg IB; Hansson K; Lindgren A
Vet Pathol; 1993 Jan; 30(1):20-7. PubMed ID: 8442324
[TBL] [Abstract][Full Text] [Related]
2. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological prognostic factors in canine mammary tumors.
Pérez Alenza MD; Peña L; Nieto AI; Castaño M
Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
de Araújo MR; Campos LC; Ferreira E; Cassali GD
J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
Chang SC; Chang CC; Chang TJ; Wong ML
J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of DNA ploidy in canine mammary tumors.
Rutteman GR; Cornelisse CJ; Dijkshoorn NJ; Poortman J; Misdorp W
Cancer Res; 1988 Jun; 48(12):3411-7. PubMed ID: 3370639
[TBL] [Abstract][Full Text] [Related]
9. Comparison of histology and clinical variables to DNA ploidy in canine mammary tumors.
Hellmén E; Lindgren A; Linell F; Matsson P; Nilsson A
Vet Pathol; 1988 May; 25(3):219-26. PubMed ID: 3394213
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
12. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors.
Ayl RD; Couto CG; Hammer AS; Weisbrode S; Ericson JG; Mathes L
Vet Pathol; 1992 Sep; 29(5):386-90. PubMed ID: 1413405
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA ploidy analysis of feline mammary tumors.
Minke JM; Cornelisse CJ; Stolwijk JA; Kuipers-Dijkshoorn NJ; Rutteman GR; Misdorp W
Cancer Res; 1990 Jul; 50(13):4003-7. PubMed ID: 2354449
[TBL] [Abstract][Full Text] [Related]
14. The accuracy of cytology in diagnosis and DNA analysis of canine mammary tumours.
Hellmén E; Lindgren A
J Comp Pathol; 1989 Nov; 101(4):443-50. PubMed ID: 2607016
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry of canine mammary tumours: the relationship of DNA ploidy and S-phase fraction to clinical and histological features.
Pérez Alenza MD; Rutteman GR; Kuipers-Dijkshoorn NJ; Peña L; Montoya A; Misdorp W; Cornelisse CJ
Res Vet Sci; 1995 May; 58(3):238-43. PubMed ID: 7659848
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
Bergers E; van Diest PJ; Baak JP
Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
[TBL] [Abstract][Full Text] [Related]
18. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
19. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
20. Prognostic status of p53 gene mutation in canine mammary carcinoma.
Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
